ID   BRSK1_HUMAN             Reviewed;         794 AA.
AC   Q8TDC3; Q5J5B5; Q8NDD0; Q8NDR4; Q8TDC2; Q96AV4; Q96JL4;
DT   29-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   05-OCT-2010, entry version 82.
DE   RecName: Full=BR serine/threonine-protein kinase 1;
DE            EC=2.7.11.1;
DE   AltName: Full=SAD1 kinase;
DE   AltName: Full=Serine/threonine-protein kinase SAD-B;
GN   Name=BRSK1; Synonyms=KIAA1811, SAD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME REGULATION,
RP   PHOSPHORYLATION AT THR-205, AND MUTAGENESIS OF THR-205.
RX   PubMed=14976552; DOI=10.1038/sj.emboj.7600110;
RA   Lizcano J.M., Goeransson O., Toth R., Deak M., Morrice N.A.,
RA   Boudeau J., Hawley S.A., Udd L., Maekelae T.P., Hardie D.G.,
RA   Alessi D.R.;
RT   "LKB1 is a master kinase that activates 13 kinases of the AMPK
RT   subfamily, including MARK/PAR-1.";
RL   EMBO J. 23:833-843(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Inoue E., Ohtsuka T.;
RL   Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF LYS-75.
RC   TISSUE=Testis;
RX   PubMed=15150265; DOI=10.1074/jbc.M404728200;
RA   Lu R., Niida H., Nakanishi M.;
RT   "Human SAD1 kinase is involved in UV-induced DNA damage checkpoint
RT   function.";
RL   J. Biol. Chem. 279:31164-31170(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RA   She X.Y., Yu L., Guo J.H.;
RL   Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 51-794.
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 80-794.
RC   TISSUE=Brain;
RX   MEDLINE=21245130; PubMed=11347906; DOI=10.1093/dnares/8.2.85;
RA   Nagase T., Nakayama M., Nakajima D., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XX.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 8:85-95(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 303-794.
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-579, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-463 AND SER-524, AND
RP   MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [10]
RP   VARIANTS [LARGE SCALE ANALYSIS] TRP-319; ILE-335; GLU-407; ASN-547;
RP   SER-765 AND ALA-780.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Required for the polarization of forebrain neurons which
CC       endows axons and dendrites with distinct properties, possibly by
CC       locally regulating phosphorylation of microtubule-associated
CC       proteins (By similarity). May be involved in the regulation of
CC       G2/M arrest in response to UV- or methyl methane sulfonate (MMS)-
CC       induced, but not IR-induced, DNA damage. Phosphorylates WEE1 and
CC       CDC25B in vitro and CDC25C in vitro and in vivo.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by phosphorylation on Thr-205 by
CC       STK11 in complex with STE20-related adapter-alpha (STRAD alpha)
CC       pseudo kinase and CAB39.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Nuclear in the
CC       absence of DNA damage. Translocated to the nucleus in response to
CC       UV- or MMS-induced DNA damage.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TDC3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TDC3-2; Sequence=VSP_008158;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest levels in brain
CC       and testis. Protein levels remain constant throughout the cell
CC       cycle.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. AMPK subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 UBA domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH16681.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY505124; AAS86442.1; -; mRNA.
DR   EMBL; AY458602; AAS10354.1; -; mRNA.
DR   EMBL; AF479826; AAL87697.1; -; mRNA.
DR   EMBL; AF479827; AAL87698.1; -; mRNA.
DR   EMBL; AL831945; CAD38595.1; -; mRNA.
DR   EMBL; AL834275; CAD38950.2; -; mRNA.
DR   EMBL; AB058714; BAB47440.1; -; mRNA.
DR   EMBL; BC016681; AAH16681.1; ALT_INIT; mRNA.
DR   IPI; IPI00148020; -.
DR   IPI; IPI00185438; -.
DR   RefSeq; NP_115806.1; -.
DR   UniGene; Hs.182081; -.
DR   ProteinModelPortal; Q8TDC3; -.
DR   SMR; Q8TDC3; 47-302.
DR   STRING; Q8TDC3; -.
DR   PhosphoSite; Q8TDC3; -.
DR   PRIDE; Q8TDC3; -.
DR   Ensembl; ENST00000326848; ENSP00000320853; ENSG00000160469.
DR   GeneID; 84446; -.
DR   KEGG; hsa:84446; -.
DR   UCSC; uc002qkf.1; human.
DR   UCSC; uc002qkg.1; human.
DR   CTD; 84446; -.
DR   GeneCards; GC19P055795; -.
DR   H-InvDB; HIX0015461; -.
DR   HGNC; HGNC:18994; BRSK1.
DR   HPA; HPA021212; -.
DR   MIM; 609235; gene.
DR   PharmGKB; PA134888976; -.
DR   eggNOG; prNOG15785; -.
DR   HOVERGEN; HBG007240; -.
DR   InParanoid; Q8TDC3; -.
DR   PhylomeDB; Q8TDC3; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 74213; -.
DR   ArrayExpress; Q8TDC3; -.
DR   Bgee; Q8TDC3; -.
DR   CleanEx; HS_BRSK1; -.
DR   Genevestigator; Q8TDC3; -.
DR   GermOnline; ENSG00000160469; Homo sapiens.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IC:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0030010; P:establishment of cell polarity; ISS:UniProtKB.
DR   GO; GO:0031572; P:G2/M transition DNA damage checkpoint; IDA:UniProtKB.
DR   GO; GO:0030182; P:neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   GO; GO:0009411; P:response to UV; IDA:UniProtKB.
DR   InterPro; IPR020671; BR_Ser/Thr_prot_kinase.
DR   InterPro; IPR020636; Ca/CaM-dep_prot_kinase-like.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   InterPro; IPR015940; UBA/transl_elong_EF1B_N_euk.
DR   PANTHER; PTHR22982:SF59; BR_Ser/Thr_prot_kinase; 1.
DR   PANTHER; PTHR22982; Ca/CaM-dep_prot_kinase-like; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50030; UBA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Kinase; Magnesium; Metal-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    794       BR serine/threonine-protein kinase 1.
FT                                /FTId=PRO_0000085669.
FT   DOMAIN       50    301       Protein kinase.
FT   DOMAIN      330    372       UBA.
FT   NP_BIND      56     64       ATP (By similarity).
FT   COMPBIAS    508    556       Pro-rich.
FT   ACT_SITE    172    172       Proton acceptor (By similarity).
FT   BINDING      79     79       ATP (By similarity).
FT   MOD_RES     205    205       Phosphothreonine.
FT   MOD_RES     209    209       Phosphoserine (By similarity).
FT   MOD_RES     463    463       Phosphoserine.
FT   MOD_RES     524    524       Phosphoserine.
FT   MOD_RES     579    579       Phosphoserine.
FT   VAR_SEQ       1     42       MVAGLTLGKGPESPDGDVSVPERKDEVAGGGGEEEEAEERG
FT                                R -> MSSGAKEGGGGSPAYHLPHPHPHPPQ (in
FT                                isoform 2).
FT                                /FTId=VSP_008158.
FT   VARIANT     319    319       R -> W (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040394.
FT   VARIANT     335    335       V -> I (in a lung large cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040395.
FT   VARIANT     407    407       G -> E (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_040396.
FT   VARIANT     547    547       T -> N (in dbSNP:rs55892637).
FT                                /FTId=VAR_040397.
FT   VARIANT     765    765       G -> S.
FT                                /FTId=VAR_040398.
FT   VARIANT     780    780       P -> A (in dbSNP:rs55796422).
FT                                /FTId=VAR_040399.
FT   MUTAGEN      75     75       K->A: Loss of kinase activity.
FT   MUTAGEN     205    205       T->A: Prevents phosphorylation and
FT                                activation by STK11 complex.
FT   CONFLICT    778    778       G -> A (in Ref. 7; AAH16681).
SQ   SEQUENCE   794 AA;  86753 MW;  5DD395B0E61AEF77 CRC64;
     MVAGLTLGKG PESPDGDVSV PERKDEVAGG GGEEEEAEER GRHAQYVGPY RLEKTLGKGQ
     TGLVKLGVHC ITGQKVAIKI VNREKLSESV LMKVEREIAI LKLIEHPHVL KLHDVYENKK
     YLYLVLEHVS GGELFDYLVK KGRLTPKEAR KFFRQIVSAL DFCHSYSICH RDLKPENLLL
     DEKNNIRIAD FGMASLQVGD SLLETSCGSP HYACPEVIKG EKYDGRRADM WSCGVILFAL
     LVGALPFDDD NLRQLLEKVK RGVFHMPHFI PPDCQSLLRG MIEVEPEKRL SLEQIQKHPW
     YLGGKHEPDP CLEPAPGRRV AMRSLPSNGE LDPDVLESMA SLGCFRDRER LHRELRSEEE
     NQEKMIYYLL LDRKERYPSC EDQDLPPRND VDPPRKRVDS PMLSRHGKRR PERKSMEVLS
     ITDAGGGGSP VPTRRALEMA QHSQRSRSVS GASTGLSSSP LSSPRSPVFS FSPEPGAGDE
     ARGGGSPTSK TQTLPSRGPR GGGAGEQPPP PSARSTPLPG PPGSPRSSGG TPLHSPLHTP
     RASPTGTPGT TPPPSPGGGV GGAAWRSRLN SIRNSFLGSP RFHRRKMQVP TAEEMSSLTP
     ESSPELAKRS WFGNFISLDK EEQIFLVLKD KPLSSIKADI VHAFLSIPSL SHSVLSQTSF
     RAEYKASGGP SVFQKPVRFQ VDISSSEGPE PSPRRDGSGG GGIYSVTFTL ISGPSRRFKR
     VVETIQAQLL STHDQPSVQA LADEKNGAQT RPAGAPPRSL QPPPGRPDPE LSSSPRRGPP
     KDKKLLATNG TPLP
//
